M1A.2510 Drug-induced chronic gout, right hip, without tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Right Hip, Without Tophus (tophi)

Summary

Drug-induced chronic gout, right hip, without tophus is a form of arthritis affecting the right hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the formation of tophi (urate crystal deposits) in this stage.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense right hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Stiffness and limited range of motion in the right hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis may detect urate crystals. Imaging, such as X-rays or ultrasound, assesses joint damage and rules out other conditions. The absence of tophi is confirmed clinically or via imaging.

Treatment Options

Treatment focuses on reducing uric acid levels and managing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., NSAIDs or colchicine). Lifestyle modifications, such as dietary changes, may also be recommended. The underlying medication causing gout should be reviewed and adjusted if possible.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels, adjust medications, and assess joint function. Long-term adherence to treatment improves outcomes and reduces flare-ups.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, persistent pain, and reduced mobility in the right hip. Rarely, severe inflammation could cause joint deformity or functional impairment.

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible.
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood).
• Stay hydrated to support uric acid excretion.
• Limit alcohol, especially beer, which can increase uric acid.

When to Seek Professional Help

Seek medical attention if you experience sudden, severe right hip pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is important to prevent joint damage.

Tips for Medical Coders

Document the specific site (right hip) and the absence of tophi clearly in the medical record. Ensure the causal medication is noted, as this distinguishes drug-induced gout from other forms. Verify that the code M1A.2510 is used only when tophi are not present.